Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study - Concepedia

Concepedia

Publication | Open Access

Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study

DOI Full Paper Access

313

Citations

31

References

2008

Year

Peter J. Zed, Riyad B. Abu‐Laban, Robert M. Balen, Peter Loewen, Corinne M. Hohl, Jeffrey R. Brubacher, Kerry Wilbur, Matthew O. Wiens, Leslie Jo Samoy, Katie Lacaria,

Canadian Medical Association Journal

Abstract

More than 1 in 9 emergency department visits are due to drug-related adverse events, a potentially preventable problem in our health care system.

References

	Year	Citations
A method for estimating the probability of adverse drug reactions C. A. Naranjo, U. Busto, Edward M. Sellers, Clinical Pharmacology & Therapeutics DiagnosisPharmacotherapyLogistic AnalysisAdverse Drug ReactionDrug Resistance	1981	11.4K
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients Munir Pirmohamed, Sally James, Shaun Meakin, BMJ	2004	3.2K
Opportunities and responsibilities in pharmaceutical care Charles D. Hepler, Linda M. Strand American Journal of Health-System Pharmacy Drug DispensingAdverse Drug ReactionPrimary CarePharmaceutical PracticeClinical Pharmacy	1990	2.9K
The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada G. Ross Baker Canadian Medical Association Journal	2004	2.3K
Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting Jerry H. Gurwitz, Terry S. Field, Leslie R. Harrold, JAMA	2003	1.7K
The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group David W. Bates JAMA Preventive MedicineHealth SciencesHealth EconomicsHealth PolicyAdverse Event	1997	1.4K
National Surveillance of Emergency Department Visits for Outpatient Adverse Drug Events Daniel S. Budnitz, Daniel A. Pollock, Kelly N. Weidenbach, JAMA	2006	883
Drug-Related Morbidity and Mortality: Updating the Cost-of-Illness Model Frank R. Ernst, Amy J. Grizzle Journal of the American Pharmaceutical Association (1996) Health PolicyHealth EconomicsPharmacoeconomicsHealth Care CostPublic Health	2001	851
Drug-related morbidity and mortality. A cost-of-illness model Jeffrey Johnson Archives of Internal Medicine Health EconomicsPharmacoeconomicsHealth Care CostDrug-related MorbidityPublic Health	1995	804
Clarifying Adverse Drug Events: A Clinician's Guide to Terminology, Documentation, and Reporting Jonathan R. Nebeker, Paul Barach, Matthew H. Samore Annals of Internal Medicine Drug SafetyDrug HypersensitivitySubstance AbuseAdverse Drug EventSuspect Drug	2004	787

Page 1